大葉大學圖書館 |

Individualized medicine[electronic resource] :ethical, economical and historical perspectives /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	610.7
書名/作者:	Individualized medicine : ethical, economical and historical perspectives // edited by Tobias Fischer ... [et al.].
其他作者:	Fischer, Tobias.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	xvi, 323 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Personalized medicine.
標題:	Biomedicine.
標題:	Biomedicine general.
標題:	Theory of Medicine/Bioethics.
標題:	Ethics.
標題:	Economics/Management Science, general.
標題:	History.
ISBN:	9783319117195 (electronic bk.)
ISBN:	9783319117188 (paper)
內容註:	Preface -- Introduction -- Definition and concept of Individualized Medicine -- Perspectives of socio-cultural and historical studies -- Medical perspectives -- Concept-based ethical questions -- Applied research ethics -- Health economic assessment of Individualized Medicine -- Conclusions and recommendations -- Index.
摘要、提要註:	In 2009 the University Medicine Greifswald launched the "Greifswald Approach to Individualized Medicine" (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes - next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients - chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the German health care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.
電子資源:	http://dx.doi.org/10.1007/978-3-319-11719-5

Individualized medicine[electronic resource] :ethical, economical and historical perspectives /
Individualized medicineethical, economical and historical perspectives /[electronic resource] :edited by Tobias Fischer ... [et al.]. - Cham :Springer International Publishing :2015. - xvi, 323 p. :ill., digital ;24 cm. - Advances in predictive, preventive and personalised medicine,v.72211-3495 ;. - Advances in predictive, preventive and personalised medicine ;v.1..

Preface -- Introduction -- Definition and concept of Individualized Medicine -- Perspectives of socio-cultural and historical studies -- Medical perspectives -- Concept-based ethical questions -- Applied research ethics -- Health economic assessment of Individualized Medicine -- Conclusions and recommendations -- Index.

In 2009 the University Medicine Greifswald launched the "Greifswald Approach to Individualized Medicine" (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes - next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients - chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the German health care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.

ISBN: 9783319117195 (electronic bk.)

Standard No.: 10.1007/978-3-319-11719-5doiSubjects--Topical Terms:

606514
Personalized medicine.

LC Class. No.: R853.P47

Dewey Class. No.: 610.7

Individualized medicine[electronic resource] :ethical, economical and historical perspectives /
LDR:02536nam a2200325 a 4500 001 426462
003 DE-He213
005 20150904143158.0
006 m d
007 cr nn 008maaau
008 151119s2015 gw s 0 eng d
020 $a 9783319117195 (electronic bk.)
020 $a 9783319117188 (paper)
024 7 $a 10.1007/978-3-319-11719-5 $2 doi
035 $a 978-3-319-11719-5
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.P47
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
082 0 4 $a 610.7 $2 23
090 $a R853.P47 $b I39 2015
245 0 0 $a Individualized medicine $h [electronic resource] : $b ethical, economical and historical perspectives / $c edited by Tobias Fischer ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xvi, 323 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in predictive, preventive and personalised medicine, $x 2211-3495 ; $v v.7
505 0 $a Preface -- Introduction -- Definition and concept of Individualized Medicine -- Perspectives of socio-cultural and historical studies -- Medical perspectives -- Concept-based ethical questions -- Applied research ethics -- Health economic assessment of Individualized Medicine -- Conclusions and recommendations -- Index.
520 $a In 2009 the University Medicine Greifswald launched the "Greifswald Approach to Individualized Medicine" (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes - next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients - chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the German health care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.
650 0 $a Personalized medicine. $3 606514
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Biomedicine general. $3 463541
650 2 4 $a Theory of Medicine/Bioethics. $3 464016
650 2 4 $a Ethics. $3 177847
650 2 4 $a Economics/Management Science, general. $3 463723
650 2 4 $a History. $3 349095
700 1 $a Fischer, Tobias. $3 606513
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Advances in predictive, preventive and personalised medicine ; $v v.1. $3 490642
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-11719-5
950 $a Medicine (Springer-11650)